- Presentation Title: Pre-Award Activities Contract: Budgeting for Clinical Trials
- Presented by Melissa L. Archer
- Learning Goals
- Compliance with Medicare Secondary Payer Act
- Federal Anti-Kickback Laws – Budget Development
- Medicare Coverage Analysis
- Essential Terms in Clinical Trial Agreements
- Driving Legal Concerns
- At USC, trials must be compliant of Medicare Secondary Payor Act (“MSP”)
- Expenses such as what will not be covered by private insurance and Medicare must be covered by the sponsor
- Federal Anti-Kickback Laws/Stark Laws
- Fair market value
- No discounts! The data needs to look clean.
- No endorsements for free supply of medications
- Safe Harbors: Everything must be outlined and written in a contract
- Sunshine Act--- it is the responsibility of the sponsors to gather, organize, and interpret this information; objective- transparency
- At USC, trials must be compliant of Medicare Secondary Payor Act (“MSP”)
- Budgeting and Contracting
- Budgeting Tools: Standardized Fees
- Fixed Start-Up Fees
- Fixed IRB Fees
- Research (CPT) Fees
- Research (Non-CPT) Fees
- Elements of a Sponsored Research Agreement
- Confidential Information
- Patent Privacy and Use of Protected Health Information
- Study Data
- Publication
- Protection of Inventions
- Identification
- Subject Injury Reimbursement
- Budget and Payment Schedule
- Budgeting Tools: Standardized Fees
- Final Take-Aways
- Research must be fully costed
- Agreement should cover all essential elements
- Early PI participation is important for a quick start of study
- Understand confidentiality obligations
- Presentation Title: Managing Study Set-Up Logistics: Study Drug, Specimen, Space
- Presented by Diana Palma BS, CCRP and Regina Olivas, RN, BSN, MSW
- Logistical Considerations
- Storage of Research Charts
- Feasibility of the Study
- Required Training specific to the protocol
- Who is the sponsor?
- Data Entry Systems--- which system can used for which function? (ex. A particular system may store data only while another stores patient info etc.)
- Organizing Research Charts
- Is there a study drug involved?
- IRB Approval
- Feasibility
- Determined by PI and research team
- Bring up protocol, location, staff, or technical concerns early on
- Anticipated study enrollment expectations reviewed by all study staff
- Reaching out to Ancillary Services: Radiology, pharmacy, lab
- To ensure that protocol procedures fall within institutional scope of practice
- Staff In-services/Education
- Tailor presentations to audiences ie. Clerical staff vs. clinical nurses and physicians
- Performed by PI, CRC
- Additional services should be performed with study protocol amendments and inform all staff
- Study Drug Management
- Involve the Investigational Drug (ID) Pharmacy
- ID Pharmacy can help with regulatory compliance integrity of blinding, preventing of errors involving drug study, dispensing the drug in timely fashion etc.
- Involve the Investigational Drug (ID) Pharmacy
- Specimen Storage & Handling
- Following topics are presented by Regina Olivas, RN, BSN, MSW
- Collaborate with lab and pathology
- Where will your specimens be stored and how to be handled?
- Need for refrigerators and freezers
- Assess equipment ie. Centrifuges and training on how to use equipment
- No Space may result in Off-site locations
- Make sure that shipping specimens are shipped in a timely manner and consider weather conditions of journey and final destination
- Space Considerations
- Research files should be in lockable file cabinets
- Access to study staff workstation, research supply, and study drug
- Monitor Site Visits
- May be a few individuals or a whole team
- Need a private work space for routine visits
- Record Storage: Ongoing Studies
- Central location with the documentation
- All research charts should be accessible in case of audit
- Creating Standard Operating Procedure (SOP)
- Record Storage: Closed Studies
- Check with institutional policies before moving or discarding research records
- ex. Cancer studies are ongoing -> research concerning cancer should be maintained
- Conclusion